Illumina Inc. (ILMN)
Bid | 87 |
Market Cap | 13.88B |
Revenue (ttm) | 4.36B |
Net Income (ttm) | -1.22B |
EPS (ttm) | -7.69 |
PE Ratio (ttm) | -11.39 |
Forward PE | 30.01 |
Analyst | Buy |
Ask | 88 |
Volume | 1,750,789 |
Avg. Volume (20D) | 2,400,745 |
Open | 83.74 |
Previous Close | 84.79 |
Day's Range | 84.10 - 87.85 |
52-Week Range | 80.18 - 156.66 |
Beta | 1.17 |
About ILMN
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequenci...
Analyst Forecast
According to 18 analyst ratings, the average rating for ILMN stock is "Buy." The 12-month stock price forecast is $147.5, which is an increase of 68.34% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription

3 weeks ago · seekingalpha.com
Illumina, Inc. (ILMN) AGBT Investor Session Conference (Transcript)Illumina, Inc. (NASDAQ:ILMN ) AGBT Investor Session Conference February 25, 2025 11:00 AM ET Company Participants Salli Schwartz - Head of Investor Relations Jacob Thaysen - Chief Executive Officer St...